Lextro Labs

Hyderabad, India Founded: 2022 • Age: 4 yrs
Develops first-in-class biotherapeutics for cancer, autoimmune, metabolic, and infectious diseases using ImCy platform.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Lextro Labs

Lextro Labs is a company based in Hyderabad (India) founded in 2022 by Akkina Srinivas Chowdary and Murali K Addepalli. It operates as a B2B. The company has 1 employees. Lextro Labs offers products and services including ImCy Platform and Biotherapeutics Pipeline. Lextro Labs operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter Hyderabad, India
  • Employees 1 as on
  • Founders Akkina Srinivas Chowdary, Murali K Addepalli
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lextro Labs Private Limited
  • Date of Incorporation 22 Jun, 2022
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lextro Labs

Lextro Labs offers a comprehensive portfolio of products and services, including ImCy Platform and Biotherapeutics Pipeline.

Product name locked
Category locked
Primary

Technology for immune modulation and cytotoxicity in disease treatment

Product name locked
Category locked
Locked

Pipeline of therapies for cancer and autoimmune diseases

Funding Insights of Lextro Labs

Premium access

Detailed funding history for Lextro Labs

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lextro Labs

Investments
Premium access

Investment portfolio details for Lextro Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lextro Labs

Premium access

Detailed financials for Lextro Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lextro Labs Comparisons

Lextro Labs Primary company
Description
Develops first-in-class biotherapeutics for cancer, autoimmu...
Location
Hyderabad, India
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
1
As of 2026
Premium access

Peer comparison for Lextro Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lextro Labs

Lextro Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
mRNA-based therapeutics for diseases including cancer and infections are developed.
Locked Locked Locked
Novel biopharmaceutical medicines are developed for unmet medical needs.
Locked Locked Locked
Targeted and immune-oncology drugs for cancer treatment are developed.
Locked Locked Locked
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
Locked Locked Locked
Small molecules are developed for cancer and skin disease treatments.
Locked Locked Locked
Cancer therapies are developed using selective pathway inhibitors.
Premium access

Detailed competitors of Lextro Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lextro Labs

Premium access

Complete news archive for Lextro Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lextro Labs

Lextro Labs was founded in 2022.

Lextro Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of the latest available data, the latest employee count at Lextro Labs is 1.

Lextro Labs is a discovery-stage biopharmaceutical company focused on creating innovative biotherapeutics through its ImCy platform, which modulates immune responses and restores homeostasis. It targets diseases such as cancer, autoimmune disorders, metabolic conditions, and infections by identifying dysregulated pathways and developing multi-specific therapies. The company is based in Hyderabad, India, and engages in research, partnerships, and pipeline development to advance healthcare solutions.

Lextro Labs's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Lextro Labs offers ImCy Platform and Biotherapeutics Pipeline.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available